Core Insights - Juisci, a HealthTech startup, has raised €5.5 million in Seed funding to enhance R&D, expand its team, and accelerate international growth, particularly in the U.S. market [1] - The platform aims to provide healthcare professionals with quick and trustworthy access to scientific knowledge, helping them save time and combat misinformation [2][3] Company Overview - Founded in 2021 by Robin Roumengas and Dr. David Luu, Juisci is a SaaS platform that democratizes access to scientific knowledge through proprietary AI and a mobile-first experience [3] - The platform currently has over 200,000 users across 60 countries and supports 10 languages, collaborating with major pharmaceutical companies, MedTech firms, and hospitals [4][6] Market Need - The volume of medical knowledge is rapidly increasing, doubling every 73 days, making it challenging for healthcare professionals to keep up with the latest research [5] - Juisci addresses this issue by utilizing AI specifically trained on scientific literature to convert extensive research into clear and reliable insights [5] Product Features - The platform offers digestible summaries, article recommendations, videos, podcasts, and infographics, enabling healthcare professionals to save up to 8 hours a week [6] - Juisci has secured over 30 major clients, including well-known companies like Sanofi, UCB, and Johnson & Johnson, as well as various hospitals and scientific societies [7]